PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
THIS IS AN ONGOING ACTIVITY.
The purpose of the National Center for HIV/AIDS Dermatology and STDs (NCHADS) Cooperative
Agreement is to promote ongoing collaboration between NCHADS and HHS/CDC in response to the HIV
epidemic. Key focus areas of the NCHADS Cooperative Agreement include improving PMTCT coverage,
improving the Continuum of Care (CoC) for persons living with HIV/AIDS (in particular those with co-existing
TB disease) and improving the collection and use of data to inform HIV program activities.
NCHADS will promote: (1) increased community awareness of the need for HIV testing during pregnancy;
(2) expansion of HIV testing of pregnant women: (3) efficient use of trained PMTCT staff; (4) improved
follow-up of HIV-infected pregnant women after they are identified to make sure they receive PMTCT
services during labor and post-partum period; (5) adequate follow up through infant diagnosis; and (6)
provision of appropriate care for people living with HIV/AIDS (PLHA). With technical support from
HHS/CDC, NCHADS will continue and expand activities initiated in COP 08, including the following:
1. Continuing a demonstration project initiated at 15 health centers and two maternity sites in calendar year
2008. This will be continued in calendar year 2009, and will include assessing the utility and feasibility of:
(a) task-shifting HIV testing to midwives at health centers; (b) incorporating HIV testing into antenatal care
(ANC); and (c) testing women of unknown HIV status during labor at maternity sites equipped to provide
labor, post-partum, and infant ARVs.
2. Supporting four PMTCT sites in Banteay Meanchey Province and expanding to four additional sites in
the province.
3. Supporting the transport of indigent patients for HIV testing in four provinces and one municipality.
4. Supporting provincial and operational district PMTCT coordinators' participation in quarterly meetings.
5. Supporting the Annual National PMTCT Workshop. This workshop is the only opportunity for general
dissemination of updated PMTCT policies and recommendations.
6. Providing technical assistance to provincial health staff in quality improvement and monitoring and
evaluation, specifically around the problem of identified HIV-infected pregnant women being lost to follow-up
prior to their delivery.
7. Supporting leadership development within the National PMTCT Secretariat by ensuring attendance of
two Secretariat officials to a regional conference, as well as continuing to support the Secretariat Office with
English instruction and needed supplies.
ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS:
These core PMTCT activities will be supplemented with the following activities:
1. Sponsoring Train the Trainers for provincial health department staff to decentralize training and
supervision activities, which was identified in 2007 by the Interagency Task Team as a key strategy for
expanding PMTCT services;
2. Sponsoring trainings for health center midwives taught by the newly trained provincial staff to promote
provider initiated testing and counseling of pregnant women;
3. Promoting a PMTCT video soap opera which poignantly illustrates the need for HIV testing during
pregnancy. This soap opera will be shown in public, community, and health center settings as a means of
increasing consumer awareness and demand for HIV testing. This video won the 2008 International Health
and Medical Media (Freddie) Award in the category of Prevention.
New/Continuing Activity: Continuing Activity
Continuing Activity: 18467
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
18467 11302.08 HHS/Centers for National Center for 7344 7344.08 NCHADS CoAg $68,688
Disease Control & HIV/AIDS GHAI
Prevention Dermatology and
STDs
11302 11302.07 HHS/Centers for National Center for 5755 5755.07 NCHADS CoAg $80,800
Emphasis Areas
Gender
* Increasing gender equity in HIV/AIDS programs
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $40,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.01:
Almost six percent of adults in public OI/ART clinics in Cambodia receive care in Banteay Meanchey (BMC),
one of the USG's target provinces. However, BMC accounts for only 1.6% of children enrolled in HIV care
and only 1.1% of children on ART. While two hospitals in adjacent Siem Reap provide care for some
children from BMC, it is likely that there are many HIV-infected children who are undiagnosed or untreated
in the province. Factors contributing to this situation include failure to identify HIV-infected pregnant
women, high rate of loss to follow-up among pregnant women who are identified as HIV-infected, high rate
of loss to follow-up of exposed infants following delivery, and public perception that HIV pediatric care in
BMC is of sub-standard quality. Two of the province's three OI/ART clinics report having no patients less
than 15 years old.
The National Center for HIV/AIDS, Dermatology, and STDs (NCHADS) has set the expansion of pediatric
services to all 49 OI/ART clinics in Cambodiaas a major priority. HHS/CDC will support NCHADS's strategy
to improve and expand pediatric services in BMC by working to assure all HIV-exposed infants are identified
antenatally, promoting linkages to community based services that will help prevent loss to follow-up, assure
all HIV-infected pregnant women and their infants are provided with optimal prophylaxis, strengthen infant
follow-up so that all exposed infants receive DNA-PCR HIV testing at 6 weeks and again at 6 weeks post
weaning, support refresher trainings in the performance of dried blood spot PCR testing, provide informed
counseling regarding optimal infant feeding choices, ensuring that all infants found to be infected are started
on ART and co-trimoxazole as soon after diagnosis as possible, and guaranteeing that ongoing, quality
pediatric care is provided at the treatment sites in the province. Funds will be provided for mentoring of
pediatric staff, trainings for clinical staff and community support staff, quality improvement of pediatric
services, and supervision of all these linked services.
New/Continuing Activity: New Activity
Continuing Activity:
Program Budget Code: 12 - HVTB Care: TB/HIV
Total Planned Funding for Program Budget Code: $527,205
Total Planned Funding for Program Budget Code: $0
Program Area Narrative:
Cambodia has the highest estimated tuberculosis (TB) incidence (500/100,000) in Asia. It is one of the World Health
Organization's 22 "high-burden" TB countries. In 2006, the DOTS coverage was 100%, the smear-positive case-detection rate
was 62%, and in 2005 the treatment success rate was 93%.
The HIV prevalence among TB patients in Cambodia is 7.8%, far greater than the HIV prevalence of 0.8% in the general
population. At the same time, TB is very common among HIV-infected persons. Among persons newly diagnosed with HIV
infection who are screened for TB, up to 25% are diagnosed with TB disease. The National Tuberculosis program reported that in
2007 38% of new TB patients were tested for HIV infection. Of patients diagnosed with TB/HIV, 70% were treated with co-
trimoxazole preventive therapy (CPT) and 35% with antiretroviral therapy (ART). A TB drug-resistance survey has recently
completed enrollment. Preliminary data are that 1.7% of new TB patients and 8.7% of re-treatment patients had multidrug-
resistant (MDR) TB. This is an increase from the previous survey in 2002, which found no cases of MDR TB among new patients
and 3% in re-treatment patients.
TB/HIV is a priority for the USG in Cambodia. As a non-focus country with a limited budget, it is not possible to address all
aspects of TB/HIV in all areas of the country. Therefore, the plan focuses on policy and coordination-related activities at the
national level and support for specific TB/HIV-related activities in selected areas of the country, and wraparound with non-
PEPFAR USAID TB activities. These areas were chosen in collaboration with the national TB and HIV programs and complement
support provided by other donors, of which Global Fund provides the largest support. To implement these activities, USG will
again partner with the National Center for HIV/AIDS, Dermatology and STDs (NCHADS), and USAID's TB Capacity Assistance
Project (TBCAP). In addition, this year, USG will directly fund the national TB program (CENAT) in a new activity.
In COP 08, support for TB/HIV included the following main areas: (1) support for collaboration between TB and HIV programs at
the national level; (2) HIV testing of TB patients; (3) intensified TB case finding among people with HIV; (4) surveillance for and
management of drug-resistant TB; (5) strengthening of TB laboratory services; and (6) improved monitoring and evaluation; For
COP 09, activities will be continued and expanded in each of these areas. In addition, isoniazid preventive therapy (IPT)
implementation and infection control in HIV care settings will be supported.
The COP 08 included funding for USG TB/HIV staff who work actively with CENAT and NCHADS to facilitate collaboration
between the two programs. As regular participants in the TB/HIV technical working group, USG has been instrumental in
improving collaboration. During 2008, USG worked with the TWG to develop a standardized operating procedure for provider-
initiated HIV testing and counseling (PITC) for TB patients, initiated the development of a standardized operating procedure for
intensified TB case finding, IPT, and TB infection control, and contributed to the development of a TB/HIV curriculum for TB
clinicians. In COP 09, the USG will continue to support these staff to work with the national programs on collaborative TB/HIV
activities. The main focus of improved collaboration for the coming year will be on advancing intensified TB case finding, IPT, TB
infection control, and enhanced monitoring and evaluation. In addition, staff will continue to use lessons learned from successful
program implementation in USG-supported areas to enhance programs in other areas through the TB/HIV working group.
For HIV testing of TB patients, the current standard practice in Cambodia is to refer TB patients to a voluntary counseling HIV
testing (VCT) center for testing. USG has sought to: (1) maximize the proportion of TB patients tested for HIV infection under
current policy in USG-supported areas; and (2) work with the national programs to revise policy and adopt a PITC-based
approach. In COP 08, efforts were made to enhance testing under existing policy through support of patient transportation to VCT,
regular meetings between TB and HIV staff to facilitate increased HIV testing, and training of staff in standardized approaches to
talking to TB patients about the need for an HIV test. With these strategies in place, over 80% of TB patients in Banteay
Meanchey (BMC) province in Northwest Cambodia were tested for HIV infection. In 2008, this package of activities was expanded
to 2 additional USG focus provinces and Pailin Municipality; 50-60% of TB patients have been tested for HIV in the past year, well
above the 38% reported nation-wide. The COP 09 will focus on implementing PITC in these 4 USG focus areas (provinces of
Pursat, Banteay Meanchey, Battambang and Palin Municipality) and increasing the proportion of TB patients tested for HIV
infection to over 80%.
National policy is that all people living with HIV/AIDS (PLHA) should be screened for TB at initial HIV diagnosis and regularly
thereafter. In COP 08, this was supported through two efforts:
1. Regular meetings for TB and HIV staff in the northwest provinces to instruct staff in the importance of TB screening. This was
previously supported by USG in one province and was expanded to all four USG focus areas in Northwest Cambodia in 2008; and
2. USG staff worked with the TB/HIV working group to begin preparation of a standardized operating procedure for intensified TB
case finding. In the first 6 months of 2008, over 80% of people with HIV were screened for TB in the one province which has been
supported by USG since 2003. In the two provinces for which these activities were added, 80-95% were screened.
In COP 09, the efforts in the 4 USG focus areas will be continued with a target of 90% of people with HIV screened for TB. Staff
will continue to work with the TB/HIV working group on a standardized operating procedure for intensified TB case finding.
Recently, a large study of how best to screen people with HIV has been completed in Cambodia, Vietnam, and Thailand. This
study provides evidence to guide the best approach to screening. Based on its findings, the method of screening will be modified
both in USG-supported provinces and in national policy to ensure that people are being screened with the most sensitive available
methods.
As part of COP 08, USG contributed some equipment-related costs for the TB drug-resistance survey. That survey is now
complete. Through sources outside of PEPFAR, the national TB program is implementing a treatment program for patients with
MDR TB. In COP 09, the primary USG contributions to drug-resistance surveillance and management will be technical assistance
for routine surveillance for drug-resistance as part of the expansion of TB laboratory capacity.
Strengthening of TB laboratory services was an important component of the COP 08. PEPFAR funding supported USG staff who
worked with the national TB program to develop a national laboratory strategic plan. Currently, there are 3 facilities in Cambodia
capable of doing TB culture, and all 3 use solid media. In order to meet the needs of people with HIV, including more sensitive
and rapid TB diagnosis and detection of drug-resistance, the addition of liquid culture was supported in COP 08. Funding was
used to renovate one of the three culture sites, which is a site located in Battambang (a province in the northwest). COP 08
funding also supported technical assistance for liquid culture implementation and a biosafety consultation to ensure that laboratory
staff are protected. Remaining COP 08 resources are being used to support procurement of supplies and equipment needed to
implement liquid culture and training of laboratory staff. Starting in late 2009, funding from the Global Fund will cover the ongoing
costs of the culture laboratories. For COP 09, the USG will continue to support technical assistance and staff training, and will
procure supplies needed for the period before Global Fund funding starts in late 2009. In addition, USG will fund transport of
specimens from local HIV care centers to the culture facility and information systems to capture laboratory data.
COP 08 supported monitoring and evaluation of TB/HIV activities through hiring USG staff dedicated to M&E, including TB/HIV,
and by providing support to staff conducting supervision of TB/HIV activities in the northwest provinces to ensure that high quality
data were collected and data were used to enhance program performance. These activities will be continued in COP 09.
Funding for COP 09 will also support implementation of IPT for PLHA. This support will include continued work with the TB/HIV
working group on developing a standardized operating procedure for IPT, funding of training for IPT implementation, support for
training and supervision for IPT implementation in the northwest provinces, and monitoring and evaluation of implementation in
that area. The goal for the first year is that 25% of people with HIV newly presenting to the HIV care facilities in USG's four focus
area, without active TB, will be started on IPT.
USG will continue to support improvements in TB infection control to decrease the transmission of TB to HIV-infected persons.
This is being done through USAID funded wraparound TB activities. USAID supports the national TB Program (NTP), Community
DOTS (C-DOTS) and Public Private Mix (PPM). C-DOTS is implemented through a network of community volunteers who assist
health centers to increase TB case detection and observe treatment within a patient's home. C-DOTS currently covers about one
third of all health centers in Cambodia and is being expanded with Global Fund support. PPM activities improve diagnosis and
strengthen referrals between the private and public sectors, and is being implemented in over 33 Operational Districts. Through
TBCAP, USAID supports the implementation of external quality assurance in TB laboratories in 8 provinces.
Due to limited PEPFAR funds, TB-HIV activities in the following areas will be supported with USAID TB-funds: (a)
communications strategies, messages, materials and associated capacity building; (b) strengthening the referral system between
voluntary counseling and testing (VCT) and TB, increasing access to ARVs (Antiretrovirals) for TB patients and improving
diagnosis of TB in PLHA; (c) clinical TB/HIV management training and support; (d) conducting targeted evaluation research for the
improvement and expansion of Isoniazide Prophylaxis Treatment (IPT); (e) strengthening the skills of physicians to diagnose TB
as well as strengthening linkages between TB and VCT; (f) implementing and monitoring option 2 (the transport of blood from TB
patients to the nearest VCT site for HIV testing) by training health center (HC) staff on provider initiated testing and counseling
(PITC); and (g) strengthing linkages with community based care to improve the skills of village health support groups (VHSGs)
and home based care (HBC) teams in delivering TB messages and assisting in treatment adherence and referral of suspected
cases.
USG activities in the coming year are synergistic to those supported by other donors, including the Global Fund. Under PEPFAR,
USG largely supports increasing early TB and HIV diagnosis and getting patients to care. The Global Fund supports HIV care and
treatment at government ARV clinics and supports HIV testing costs. Global Fund support also covers the costs of TB treatment
at government facilities and covers the basic costs of TB diagnosis, including chest radiography and sputum smear microscopy.
Because the support largely focuses on improving government health care infrastructure and policy and developing human
resources to meet the challenges of TB and HIV, the prospect of sustainability of these activities is high.
Table 3.3.12:
epidemic. Key focus areas of the NCHADS Cooperative Agreement include improving prevention of mother
to child transmission (PMTCT) coverage, improving the Continuum of Care (CoC) for persons living with
HIV/AIDS (in particular those with co-existing TB disease) and improving the collection and use of data to
inform HIV program activities.
In COP 08, USG supported TB/HIV activities in several areas, of which two (surveillance for and
management of drug-resistant TB and strengthening of TB laboratory services) will be continued in
partnership with the National TB Program and is described in that Activity Narrative. The other activities that
were implemented in partnership with NCHADS and which will be continued in COP 09 include the
following, all of which focus on the 4 focus areas in Northwest Cambodia:
1. Improved collaboration between TB and HIV programs;
2. Supervision of TB/HIV activities and monitoring and evaluation by provincial/municipal health department
personnel in the four focus areas;
3. Improved HIV testing of TB;
4. TB screening in all people with HIV; and
5. TB infection control in HIV care settings.
In addition to these five areas of support, USG will begin support implementation of isoniazid preventive
therapy (IPT).
In each of the activities supported, USG will work to enhance collaboration between NCHADS and the TB
programs through joint planning and regular meetings between staff of the two programs. Through support
for supervision of TB/HIV activities and appropriate monitoring and evaluation, USG will ensure that data
are used to maximize program performance.
Since the development of COP 08, a revised framework for TB/HIV collaboration has been developed by
WHO/WPRO, which recommends that HIV testing of TB patients be done at the TB treatment facility rather
than at specialized HIV-testing sites to minimize contact of infectious TB patients with people living with
HIV/AIDS (PLHA). In Cambodia, a national policy is in place that dictates that patients with TB be either
referred to voluntary counseling and testing (VCT) testing sites (Option 1), have their blood drawn at a
health center and sent for testing to the nearest VCT site (Option 2), or in rare instances have HIV testing
performed by a mobile testing unit when it visits the health center (Option 3). The new framework will result
in a switch from Option 1 to Option 2 testing strategy, and funds previously designated for support of
transport of TB patients to testing sites will be redirected to help implement Option 2 in four focus areas in
Northwest Cambodia. Training materials on pre-test information and post-test counseling for TB staff,
developed by HHS/CDC, will be used to prepare health center staff for implementation of Option 2. While
this transition is taking place, USG will continue to support efforts to maximize HIV testing of TB patients
through current policy by supporting meetings of TB and HIV staff, supportive supervision, and monitoring
and evaluation. Meanwhile, on-site HIV testing of TB patients will continue to be performed at
demonstration project sites where testing is also being done of pregnant women (HHS/CDC is supporting a
demonstration project to determine if HIV testing rates of pregnant women can be improved by offering
testing on-site at health centers; this service is being extended to TB patients at these 15 sites in 2009). As
data are collected to assess cost and effectiveness of this model, they will be shared with the National TB
program and NCHADS to determine whether national policy regarding where testing is conducted should be
changed. Of all patients registered for TB treatment during the period covered by COP 09 in the four USG
focus areas, at least 80% will be tested for HIV infection. Data will be reported through the national TB
program, as per current national policy.
Another development since the submission of COP 08 has been an evidence based algorithm for the
diagnosis of TB in HIV-infected adults. In addition to providing a strategy for the most cost-effective use of
TB culture, the algorithm provides an evidence based means to rule-out TB disease using a symptom
screen. The diagnostic algorithm also provides a more standardized means for clinicians at OI/ART clinics
to diagnose or rule out TB in their patients and provides the national program with a monitoring tool that will
allow more systematic assessment of TB screening practices at OI/ART clinics. With COP 09 resources,
this new, standardized approach to TB screening will be implemented at all HIV care facilities in the four
focus areas in Northwest Cambodia. This will require training, regular meetings, and supportive supervision.
Of all patients in HIV care during the period covered by COP 09, at least 80% will be screened for TB at
least once. NCHADS is developing an electronic system to capture these data as part of their routine
program. In the interim, USG will support data collection about TB screening to monitor progress, and
results will be reported to NCHADS.
The USG will continue to support improvement in infection control at HIV care settings. The primary focus of
this support will be to develop appropriate policies at the national level and to use these policies to develop
specific plans for each HIV care facility in the four focus areas.
Finally, USG will support the introduction of isoniazid preventive therapy (IPT) in PLHA in the focus areas.
This will include support for training, supportive supervision, introduction of tools for monitoring and
evaluation, and support to use data to improve program performance. The target is for 25% of PLHA without
TB disease newly presenting to one of the HIV care facilities in the four provinces in Northwest Cambodia to
be started on IPT. The same data collection system used for TB screening will be used to monitor progress
for IPT, and results will be reported through NCHADS.
Continuing Activity: 18468
18468 11303.08 HHS/Centers for National Center for 7344 7344.08 NCHADS CoAg $47,679
11303 11303.07 HHS/Centers for National Center for 5755 5755.07 NCHADS CoAg $109,800
This initiative includes ongoing support of laboratory activities. The HHS/CDC cooperative agreement with
NCHADS will continue to partially support an integrated laboratories initiative, and provide support to
laboratories in four USG focus areas: the three provinces of Banteay Meanchey, Battambang, Pursat, and
the municipality of Pailin. ARV services are provided at 10 sites in these provinces and laboratory services
must be available to clinically monitor the care and treatment of HIV patients.
On-site technical assistance, including review of laboratory methods, standard operating procedures, and
quality assurance will be provided by the HHS/CDC laboratory analyst stationed in Battambang.
Workshops on laboratory techniques and quality assurance will be conducted in collaboration with the
National Institute of Public Health (NIPH) laboratory. USG funds will be used to support laboratory
equipment maintenance agreements and purchase quality control reagents, as necessary. In addition,
USG funds will be used to purchase laboratory equipment for laboratories in USG focus provinces where
ARV services are provided. Additionally, this initiative will support the phase 2 evaluations of HIV test kits in
order to review the HIV testing algorithm in country.
Continuing Activity: 18453
18453 11309.08 HHS/Centers for National Center for 7344 7344.08 NCHADS CoAg $34,508
11309 11309.07 HHS/Centers for National Center for 5755 5755.07 NCHADS CoAg $145,300
Table 3.3.16:
to child transmission (PMTCT) coverage, improving the continuum of care for persons living with HIV/AIDS
(in particular those with co-existing TB disease) and improving the collection and use of data to inform HIV
program activities.
NCHADS' Surveillance Unit is responsible for conducting routine sentinel surveillance and special surveys
for prevalence of HIV, sexually transmitted infections (STIs), and risk behaviors. Additionally, in
collaboration with several partners, NCHADS is responsible for developing estimates and projections of HIV
prevalence, incidence, and mortality.
NCHADS Data Management Unit is responsible for managing all of NCHADS program data (e.g., voluntary
counseling and testing [VCT], ARV, etc.) needed for monitoring care and treatment and supporting the data
management needs of the Surveillance Unit. In 2006, Data Management Teams were placed in the
Provincial AIDS Offices of 11 provinces. NCHADS plans to expand Data Management Team coverage to at
least 19 provinces by the end of 2009. Both Surveillance and Data Management Units work closely with
staff in Provincial AIDS Offices.
Until 2005, Cambodia's sentinel surveillance system had not included men who have sex with men (MSM)
as a sentinel population. Prevalence of HIV, STIs and related risk behaviors among MSM had not been
routinely monitored. NCHADS included MSM in a cross-sectional IBBS for the first time in 2005. NCHADS
will conduct a follow-up IBBS in 2009-10 in 5 priority provinces (Phnom Penh, Kampong Cham,
Battambang, Sihanoukville, and Banteay Meanchey) among three target populations: female sex workers,
police (a sentinel group which has served as a proxy for clients of female sex workers in several previous
Cambodian surveys), and MSM. MSM will be tested for HIV as well as STIs, and will receive confidential
pre- and post-test HIV counseling and their HIV test results. Technical assistance in protocol development
and data collection, analysis, and interpretation will be provided by the USG (Family Health International
[FHI] and CDC). This survey is projected to cost over $200,000 and the USG will provide partial funding
over the two years required to plan the survey; obtain ethical approvals; conduct in-country training, field
work, and laboratory testing of biologic specimens; analyze and interpret the survey data; disseminate the
survey results; and publish the final report of survey findings. Partial funds for IBBS were initially requested
in COP 08. Because the start of this project and an HIV Sentinel Survey has been delayed, partial funding
should already be available for NCHADS to implement the IBBS. The USG will also support IBBS laboratory
and quality control testing to recipients.
In COP 09, USG will support the procurement of supplies, training and conferences for the NCHADS
Surveillance Unit.
Finally, USG will support NCHADS data management and monitoring and evaluation activities. NCHADS
Data Management Unit will continue to collect program data needed to monitor VCT and Continuum of Care
(CoC) programs as well as support surveillance data entry and management. The unit will continue to be
supported primarily by WHO with technical assistance provided by USG as requested. USG funds will be
used to provide computer equipment and support training on data collection, analysis, use, and
management in USG's four focus areas (Banteay Meanchey, Battambang, and Pursat provinces and Pailin
municipality).
Continuing Activity: 18470
18470 11310.08 HHS/Centers for National Center for 7344 7344.08 NCHADS CoAg $175,000
11310 11310.07 HHS/Centers for National Center for 5755 5755.07 NCHADS CoAg $190,800
Estimated amount of funding that is planned for Human Capacity Development $6,000
Table 3.3.17:
